ReviewJournal of nanobiotechnology2026

Nanomaterials targeting cancer-associated fibroblasts to overcome stromal barriers in cancer immunotherapy.

Zhongsong Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.